How Biogen’s Discontinued Alzheimer’s Drug Got A Second Life
“My first reaction was to be angry,” says JoAnn Wooding. “I’ve gotten over that, and frustration is more the word right now.” Wooding’s husband, Peter, who was diagnosed with Alzheimer’s in 2016, was among the more than 3,200 people with the disease who volunteered to test a promising drug called aducanumab. Made by Biogen, a … Read more